Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. (SNSE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SNSE · as of Jun 9, 2026
Key Statistics
Explore Sensei Biotherapeutics, Inc. Data
snse stock data · financialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 66.7%
The SNSE analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $50.00, representing +284.62% upside from the current price of $13.00.
Competitors & Peers
snse competitorsSNSE
AEON
BOLT
CING
CLRB
COCPAbout Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. (SNSE) is a biopharmaceutical firm dedicated to discovering and advancing immunotherapies, primarily for cancer treatment. The company's innovative approaches include its …
what is sensei biotherapeutics, inc. · snse stock overview · sensei biotherapeutics, inc. company profile · who is sensei biotherapeutics, inc. ceo · snse NASDAQ · sensei biotherapeutics, inc. headquarters · sensei biotherapeutics, inc. business segments
About Stock Overview & Key Data
Sensei Biotherapeutics, Inc. (SNSE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 4, 2021. As of the latest trading session, SNSE stock price is $13.00, with a market capitalization of $17.4M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Sensei Biotherapeutics, Inc. (SNSE) stock price is $13.00. The stock is traded on NASDAQ under the ticker symbol SNSE. The 52-week range is $5.60 – $36.76.